SCHEMBL3053047

SCHEMBL3053047

COc1cc2cnnc(N3CCC(c4cccc(O)c4)CC3)c2cc1OC

nearest known ligand 0.57

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 4/20 0.57
LMNA P02545 1/20 0.43
KMT2A Q03164 1/20 0.43
DRD2 P14416 4/20 0.42
MTOR P42345 1/20 0.42
NTSR1 P30989 1/20 0.41
DRD3 P35462 2/20 0.39
SOS1 Q07889 1/20 0.39
HIF1A Q16665 1/20 0.38
RET P07949 1/20 0.38
C1S P09871 1/20 0.38
PDE3B Q13370 1/20 0.38
PDE3A Q14432 1/20 0.38
QDPR P09417 1/20 0.38
HTR1A P08908 1/20 0.38
DRD1 P21728 1/20 0.38
DRD4 P21917 1/20 0.38
DRD5 P21918 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3055226 0.88 PDE10A (0.56) PDE10ALMNAKMT2ADRD2NTSR1
SCHEMBL3056928 0.86 PDE10A (0.42) PDE10ALMNAKMT2ADRD2MTOR
SCHEMBL3046474 0.85 PDE10A (0.53) PDE10ALMNAKMT2AMTORNTSR1
SCHEMBL3059540 0.84 PDE10A (0.57) PDE10ALMNAKMT2AMTORNTSR1
SCHEMBL3051870 0.81 PDE10A (0.51) PDE10ALMNAKMT2ANTSR1HTR1A
SCHEMBL11307305 0.80 PDE10A (0.59) PDE10ALMNAKMT2ANTSR1
SCHEMBL3049694 0.80 PDE10A (0.53) PDE10ALMNAKMT2AMTORNTSR1
SCHEMBL3059781 0.79 PDE10A (0.52) PDE10ALMNAKMT2ANTSR1PDE3B
SCHEMBL3059755 0.79 PDE10A (0.54) PDE10ALMNAKMT2ANTSR1SOS1
SCHEMBL3046918 0.78 PDE10A (0.53) PDE10ALMNAKMT2ANTSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100222353-A1 AMINOPHTHALAZINE DERIVATIVE COMPOUNDS PFIZER PRODUCTS INC. (US) 2010-09-02 US claimed
EP-1981868-A2 AMINOPHTHALAZINE DERIVATIVE COMPOUNDS Pfizer Products Inc. (US) 2008-10-22 EP claimed
WO-2007085954-A2 AMINOPHTHALAZINE DERIVATIVE COMPOUNDS PFIZER PRODUCTS INC. (US) 2007-08-02 WO claimed
US-20100222353-A1 AMINOPHTHALAZINE DERIVATIVE COMPOUNDS PFIZER PRODUCTS INC. (US) 2010-09-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100222353-A1 AMINOPHTHALAZINE DERIVATIVE COMPOUNDS PDE12, PDE5A, PDE2A PDE10A 6/4885LMNA 4217/4885KMT2A 1399/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.